本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Aura Biosciences, Inc.

7.06
-0.0300-0.42%
盤後7.060.00000.00%17:17 EDT
成交量:28.57萬
成交額:199.61萬
市值:4.53億
市盈率:-4.01
高:7.07
開:7.02
低:6.86
收:7.09
52周最高:7.48
52周最低:4.35
股本:6,415.05萬
流通股本:3,666.37萬
量比:0.95
換手率:0.78%
股息:- -
股息率:- -
每股收益(TTM):-1.7599
每股收益(LYR):-1.7599
淨資產收益率:-73.52%
總資產收益率:-40.06%
市淨率:3.31
市盈率(LYR):-4.01

資料載入中...

2022/05/12

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/03/23

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2022/03/23

重要事件披露

8-K - Current report
2022/03/23

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2022/02/14

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/10

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/01/26

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/11/24

重要事件披露

8-K - Current report
2021/11/24

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/11/12

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/11/12

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/11/10

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/11/10

超過5%披露

SC 13D - General statement of acquisition of beneficial ownership
2021/11/04

超過5%披露

SC 13D - General statement of acquisition of beneficial ownership
2021/11/02

重要事件披露

8-K - Current report
2021/10/29

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2021/10/26

SEC問詢函

CORRESP [Cover] - Correspondence
2021/10/26

SEC問詢函

CORRESP [Cover] - Correspondence
2021/10/25

[修訂]招股説明書

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933